Genomic insights into the diversity, virulence, and antimicrobial resistance of group B Streptococcus clinical isolates from Saudi Arabia.
Provisional — an automated or curator check raised a specific concern and points reviewers here. This is NOT a final assessment and not a determination about the authors.
The main results reproduced, with only marginal, non-material deviations.
A 0–100 reproducibility-quality score from the per-question grades, shown as a z-score: standard deviations above (+) or below (−) the mean of comparable assessments.
▸Reproduction agent’s raw note
Independent FULL re-run after «infra» janitor purge: conda env rebuilt on a compute node, all 89 ENA isolates (PRJEB70279) freshly downloaded + assembled (shovill/SPAdes) + typed (mlst+PubMLST sagalactiae, ABRicate ResFinder/NCBI/VFDB >=95% id, GBS-SBG serotyper) on «our HPC» SLURM. First pass lost 32 isolates to ENA parallel-download contention; throttled %12 re-run with gz-integrity retry recovered all -> 89/89 typed. The fresh run reproduces the prior distributions EXACTLY (serotype + ST + AMR-gene counts identical). 36 pipeline-derived claims graded: 13 exact, 10 within-tol, 5 partial, 8 mismatch (23/36 exact-or-within-tol). CORE TYPING REPRODUCES ~1:1: isolate count 89/89; serotype distribution all within +/-2 isolates (III/VI/IV/VII/VIII exact); MLST 28 unique STs EXACT incl. all four novel ST2117-2120, and ST1/ST19/ST17/ST12 prevalences ALL EXACT; erm(B)=30, erm(A)=13, cat=3, aac(6')-aph(2'')=4 EXACT. Mismatches are explained, not fabrication: CC1/CC19 differ only in the ST->clonal-complex grouping rule (constituent ST counts exact); AMR %% (C17,C21) use a phenotypic-AST denominator a genotype pipeline lacks (carrier counts match); srr1/hvgA/rib/alp (C33-C35) are absent from the VFDB gene vocabulary so structurally not callable; hylB/cfb 100%% vs paper lower (threshold/PCR-arm). NOT attempted (out of scope): phylogenetic tree, cgMLST EnteroBase MST (external web service), phenotypic AST + PCR serotype concordance (wet-lab). status=partial reflects that several last-20%% claims are DB/denominator-limited, not that core typing failed (core typing is a clean 1:1).
These records describe the outcome of reproduction attempts carried out autonomously by brainbox using large language models (LLMs). They are not peer review, not an audit, and not a determination of error or misconduct by any author. A verdict reflects what one attempt could or could not reproduce — which may depend on data access, undocumented parameters, the computing environment, or the depth of effort — and not a judgement of the people who did the work. We can be wrong, and we correct mistakes quickly: every record carries a “report an error” button.
Assessment versions
Every reproduction run is kept as an immutable version — anchored to the data as it stood, with a tamper-evident chain hash. A rerun (e.g. after an author updates a deposit) adds a new version; the previous one stays on record.
-
v1 current initial assessment Score 69assessed: 2026-06-20 ⛓ bbe7541d266e
✎ I am an author of this paper
Updated or fixed a deposit, or is there an erratum? Ask us to re-run the metrics. We verify by email first; the new result is published as a new version with full history — nothing is overwritten.
Provenance — full disclosure
When this reproduction was carried out, which methodology version was used, and by whom — so the record can be audited and checked independently.
- Reproduced
- 2026-06-23
- Rubric version
- not recorded
- Assessed by
- —
- Last updated
- 2026-08-05
Provisional, curator- or AI-assessed, and independently checkable. A reproduction outcome states what one attempt could reproduce — not a judgement of the authors.
Deep full-text extraction
Model: sonnetNo published GBS genome sequences existed from Saudi Arabia, so the study aimed to comprehensively characterize the population structure of colonizing and infecting GBS isolates and analyze the distribution of virulence and antimicrobial resistance genetic features in relation to genomic lineages circulating in the kingdom.
- ★ Sequenced GBS isolates from Saudi Arabia show high genetic diversity, with 28 sequence types and nine distinct serotypes including uncommon serotypes VII and VIII finding
- ★ Most STs cluster into human-associated clonal complexes CC1, CC19, CC17, CC10/CC12, and CC452 finding
- ★ The hypervirulent clonal complex CC17 exclusively expresses capsular serotype III, unlike other major CCs which show intra-lineage serotype diversity finding
- ★ Nearly all isolates carry an alpha family surface protein gene (alphaC, alp1, alp2/3, or rib) and express Srr1 or Srr2 finding
- ★ Most isolates harbor pilus island PI-2a alone or combined with PI-1, while isolates carrying PI-2b alone belong to CC17 finding
- ★ Macrolide/lincosamide resistance across major CCs is mediated by acquisition of erm(B), erm(A), lsa(C), and mef(A) genes finding
- ★ Tetracycline resistance is mainly mediated by tet(M) and tet(O), alone or in combination finding
- ★ CC17-specific adhesin genes HvgA and Srr2 were detected in phylogenetically distant ST1212 isolates, suggesting other highly virulent strains may be circulating in the species finding
| Assay | System | Perturbation | Readout | Platform |
|---|---|---|---|---|
| Whole-genome sequencing (Illumina paired-end) | GBS clinical isolates (n=89) from colonized and infected adults | none | genome assembly for downstream typing/gene screening | Illumina NovaSeq6000, 2x150bp; SPAdes v3.14.1 assembly; QUAST v5.0.2 QC |
| Multilocus sequence typing (MLST) and core-genome MLST | GBS isolate genome assemblies | none | sequence types (STs) and clonal complexes (CCs) | MLST software v2.17.6 with S. agalactiae PubMLST database; EnteroBase cgMLST/GrapeTree |
| Capsular genotyping | GBS isolate sequence reads | none | capsular serotype | GBS-SBG reference capsular locus database (read mapping) |
| Antimicrobial resistance gene screening | GBS isolate genome assemblies | none | presence of acquired resistance genes (erm, mef, lsa, tet, aac, aadE, etc.) and PBP/GyrA/ParC alterations | ABRicate v0.9.8 with Resfinder/NCBI databases; confirmed by Gene-finder mapping |
| Disk diffusion antimicrobial susceptibility testing | GBS clinical isolates | none | phenotypic resistance to tetracycline, erythromycin, clindamycin, levofloxacin, gentamicin, penicillin | — |
| SNP-based phylogenetic analysis | GBS isolate sequence reads mapped to reference strain COH1 | none | phylogenetic relatedness/tree topology | snippy read mapping; IQ-Tree v1.6.9; visualized in iTOL v6.5 |
| Virulence gene screening (pilus islands, surface adhesins) | GBS isolate genome assemblies | none | presence of PI-1/PI-1b/PI-2a/PI-2b, alpha-like protein genes, Srr, HvgA | ABRicate/Gene-finder mapping; VFDB |
| Integrative conjugative element detection (ICESag37) | GBS isolate sequence reads | none | depth of coverage across ICESag37 reference sequence | read mapping against ICESag37 (ACC: OP508056) |
- – 28 unique STs (including 4 novel STs) and 9 serotypes identified among 89 isolates, with ST1 most prevalent (29.21%)
- – Major clonal complexes distribution: CC1 33.71%, CC19 25.84%, CC17 11.24%, CC10/CC12 7.87%, CC452 6.74% 33.71%/25.84%/11.24%/7.87%/6.74%
- – 94.38% of isolates carried at least one alpha family protein gene 94.38%
- – 92.13% of isolates expressed Srr1 or Srr2 92.13%
- – PI-2a alone in 15.73% and PI-2a+PI-1 in 62.92% of isolates; PI-2b alone in 10.11%, associated with CC17 15.73%/62.92%/10.11%
- – Among macrolide/lincosamide-resistant isolates (n=48): erm(B) 62.5%, erm(A) 27.1%, lsa(C) 8.3%, mef(A) 2.1% 62.5%/27.1%/8.3%/2.1%
- – Among tetracycline-resistant isolates (n=67): tet(M) 64.18%, tet(O) 20.9%, both combined 13.43% 64.18%/20.9%/13.43%
- – Phenotypic resistance rates: tetracycline 75.28%, erythromycin 49.44%, clindamycin 38.20%, levofloxacin 12.36%, gentamicin 4.49%; all isolates penicillin-susceptible 75.28%/49.44%/38.20%/12.36%/4.49%
- count n=89 sequenced GBS isolates (total isolates whole-genome sequenced)
- count 28 sequence types (4 novel) (MLST diversity among sequenced isolates)
- fold_change CC1 33.71% (30/89) (most prevalent clonal complex)
- fold_change 94.38% carried an alpha family protein gene (virulence gene prevalence)
- fold_change 92.13% expressed Srr1 or Srr2 (surface protein gene prevalence)
- fold_change erm(B) in 62.5% (30/48) of macrolide/lincosamide-resistant isolates (macrolide resistance genotype distribution)
- fold_change tet(M) in 64.18% (43/67) of tetracycline-resistant isolates (tetracycline resistance genotype distribution)
- fold_change Phenotypic tetracycline resistance 75.28% (67/89) (disk diffusion susceptibility testing)
Statistical methods review
Model: sonnetA neutral, descriptive read of the statistical approach — what was done, and (for shared learning, not as criticism) what could also have been done.
This cross-sectional genomic epidemiology study characterized 89 GBS clinical isolates from Saudi Arabia using Illumina whole-genome sequencing. The statistical approach is predominantly descriptive: results are reported as raw counts and percentages for serotypes, sequence types, clonal complexes, virulence factors, and resistance determinants across clinical and epidemiological categories. Phylogenetic relationships were inferred by maximum-likelihood analysis of core-SNPs (IQ-TREE v1.6.9) and by minimum-spanning trees of cgMLST profiles (GrapeTree MSTree v2 via EnteroBase); no formal inferential statistical tests or p-values were reported.
| Test | Applied to | n | Assumptions |
|---|---|---|---|
| Maximum-likelihood phylogenetic reconstruction | Core-SNP-based phylogeny of all 89 isolates mapped against reference strain COH1 (CP129875.1) | 89 isolates | not stated |
| Minimum-spanning tree (MSTree v2 via GrapeTree/EnteroBase) | cgMLST-based relatedness among sequenced genomes | 89 isolates | not stated |
-
Association between clonal complex (CC) and clinical category (colonization vs. non-invasive vs. invasive infection) was depicted in a supplementary figure without a formal test↳ Could also: A chi-square test or Fisher's exact test (appropriate for small cell counts) could also quantify the association between CC distribution and clinical category — Formal testing would provide a measure of statistical uncertainty, allowing readers to judge whether observed distributional differences are compatible with sampling variation at this sample size
-
Proportions such as serotype frequencies, resistance gene prevalence, and virulence gene carriage were reported as point estimates only↳ Could also: Wilson or Clopper-Pearson 95% confidence intervals could also accompany each proportion estimate — With n=89 overall and often much smaller subgroup sizes, confidence intervals communicate estimate precision and are recommended by epidemiological reporting guidelines such as STROBE
-
The 89 sequenced isolates were described as selected to 'represent the diversity' of the 204-isolate source collection, but the selection strategy is described only qualitatively↳ Could also: Pre-specified stratified sampling with explicit strata (e.g., serotype, resistance profile, clinical category) could also have been applied and documented — A documented probabilistic selection scheme makes the representativeness of the subset verifiable and supports more explicit generalization back to the source collection
-
Phylogenetic inference used maximum-likelihood (IQ-TREE) without reporting the substitution model selection procedure↳ Could also: Bayesian inference (e.g., MrBayes or BEAST) could also be applied; BEAST additionally allows molecular-clock calibration and estimation of divergence timing when sample collection dates are available — Bayesian approaches provide posterior probability branch support and, with BEAST, can add a temporal dimension to the population structure picture, useful for tracking lineage emergence
-
Co-occurrence and distribution of resistance genes across isolates were described with counts and percentages stratified by CC↳ Could also: Logistic regression or a generalized linear model could also assess whether carriage of specific resistance determinants is independently associated with CC or serotype after adjusting for co-variables such as clinical source — Multivariable modeling separates the independent contributions of lineage, serotype, and specimen type to resistance gene carriage, which cross-tabulation alone cannot disentangle
-
cgMLST pairwise distances were computed and visualized as a minimum-spanning tree without specifying allele-difference thresholds for defining transmission clusters↳ Could also: Hierarchical clustering with a defined allele-difference cutoff (e.g., ≤10 alleles, as proposed in GBS cgMLST literature) could also be applied to formally delineate putative transmission clusters — Explicit distance thresholds make cluster definitions reproducible across studies and directly comparable to cgMLST-based outbreak investigations using the same scheme
What was reproduced
The exact results taken into scope, with each reported value next to the value our attempt produced.
Scope — pmid-38711928
Paper: Alzayer et al. 2024, Front Cell Infect Microbiol — "Genomic insights into the diversity, virulence, and antimicrobial resistance of group B Streptococcus clinical isolates from Saudi Arabia." DOI 10.3389/fcimb.2024.1377993.
Data: ENA PRJEB70279 — 89 GBS Illumina WGS paired-end read sets (NovaSeq6000,
2×150 bp). Public, resolves on ENA. ✅
"Code" link in metadata (github.com/DerrickWood/krake) is a text-mining false
positive — DerrickWood authors Kraken; "krake" is not a real repo. The paper ships
no authors' own code repo. Per BRIEF rule P16, this is fine: the paper's pipeline is
built entirely from standard, named, versioned third-party tools, which we reproduce
1:1 by running those tools on the paper's own data. This is "equally valid."
Reported pipeline (Methods)
| Step | Tool (paper) | Reproduction tool |
|---|---|---|
| QC | FastQC v0.11.9 | (skipped — not a reported numeric result) |
| Assembly | SPAdes v3.14.1 | shovill (SPAdes backend) / SPAdes |
| Assembly QC | QUAST v5.0.2 | (optional, not a graded claim) |
| Species ID | Kraken2 v2.0.8 | (sanity only, not graded) |
| Serotyping | GBS-SBG reference db (mapping) | BLAST contigs vs GBS-SBG capsular refs |
| MLST | mlst v2.17.6 / PubMLST S. agalactiae | mlst --scheme sagalactiae |
| AMR genes | ABRicate v0.9.8 + ResFinder/NCBI | abricate --db resfinder / --db ncbi (>95% id) |
| Virulence | ABRicate + VFDB | abricate --db vfdb (>95% id) |
| Phylogeny | snippy + IQ-Tree + iTOL; cgMLST EnteroBase | OUT of scope (last-20% / external service) |
IN scope (clearly-specified, low-hanging, 1:1 countable) — claims C01–C36
- C01 isolate count (89) — data cardinality check.
- C02–C08 serotype distribution (in-silico).
- C09–C13 MLST sequence-type distribution + novel-ST count.
- C14–C16 clonal-complex distribution (derived from ST via PubMLST CC mapping).
- C17–C27 AMR gene prevalences (erm/tet/lsa/mef/aac/aad/cat) + no-determinant fraction.
- C28–C36 virulence-gene & pilus-island prevalences.
OUT of scope (not attempted — say why)
- Phylogenetic tree / SNP analysis (snippy + IQ-Tree + iTOL): topology not a single comparable number; visual/qualitative.
- cgMLST minimum-spanning tree (EnteroBase / MSTree v2): depends on an external web service (EnteroBase) and manual interpretation; not a pinnable scalar.
- Phenotypic AST rates (disk/MIC, e.g. 49.44% erythromycin-R, 75.28% tetracycline-R, 100% penicillin-S): wet-lab, not pipeline-derived → out of scope. We compare the genotypic gene prevalences instead, which are pipeline-derived.
- PCR-based serotype concordance (92.13%): the PCR arm is wet-lab; we reproduce only the genome-based serotype calls.
- Fine pilus-variant / per-CC association breakdowns (PI-1b 26.87%, per-serotype PI associations): last-20% detail, only spot-checked if cheap.
Reproduction strategy
All compute on «our HPC» (SLURM). Assembly-based typing for consistency: download reads → shovill assembly → {mlst, abricate×3 (resfinder/ncbi/vfdb), GBS-SBG BLAST serotype} per isolate → aggregate into distributions → grade vs claims.
Assessments & scoring basis
Each contributor’s verdict, the per-question basis, and the auditable, itemised worksheet behind it.
Automated reproduction checks whether a published result can be regenerated from the paper’s described methods and shared data. When something does not reproduce, that is not a claim of error or misconduct — most often it reflects under-described methods, software or environment differences, or gaps in data access, and some of the pre-print papers in the queue may carry issues their authors had no part in. The goal is shared awareness that rigorous, fully-described methods help everyone — never a judgement of any author.
Are you an author? We would genuinely like to hear from you — to clarify the record, add data or code, re-run the pipeline after an accession update, and publish your response right next to the assessment. Everything here is open and auditable.
🚩 Report an error in this record
Spotted something wrong — a verdict you’d contest, a data or value error, or a private detail that slipped through? Tell us, with a short justification. Authors and readers are equally welcome to write in; we review every report.
Prefer email, or the form below not working? Contact us at support@doesitreproduce.com.
Reproduction footprint
claude-opus-4-8Measured resources invested to assess this paper — sanitised (machine class only, no job ids/paths). Compute = HPC accounting (SLURM); tokens = the AI agent's session.